Financhill
Back

Sarepta Therapeutics Vs. Vertex Pharmaceuticals Industry Stock Comparison

Sell
38

SRPT
Sarepta Therapeutics

Last Price:
128.96
Seasonality Move:
11.13%
Sell
41

VRTX
Vertex Pharmaceuticals

Last Price:
473.24
Seasonality Move:
9.38%
Sell
38
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $470.36. The Score for VRTX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.19
    The current trend is moderately bullish and SRPT is experiencing slight selling pressure.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $470.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.05 Buy
Relative Strength Index (14 RSI): 58.34 Buy
Chaikin Money Flow: -9031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (120.84 - 128.84) Buy
Bollinger Bands (100): (123 - 147.2) Sell

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.97 Buy
Relative Strength Index (14 RSI): 46.98 Sell
Chaikin Money Flow: -694359 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (459.72 - 480.22) Buy
Bollinger Bands (100): (466.75 - 489.05) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 129.53 Buy
20-day SMA: 124.83 Buy
50-day SMA: 128.74 Buy
200-day SMA: 130.35 Sell
8-day EMA: 129.2 Buy
20-day EMA: 127.16 Buy
50-day EMA: 128.69 Buy
200-day EMA: 127.96 Buy

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 475.3 Sell
20-day SMA: 471.67 Sell
50-day SMA: 474.66 Sell
200-day SMA: 449.8 Buy
8-day EMA: 474.62 Sell
20-day EMA: 473.7 Sell
50-day EMA: 473.42 Sell
200-day EMA: 447.68 Buy

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.89 per share, and an increase next year of $18.49 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):